Filter Results:
(1,526)
Show Results For
- All HBS Web
(1,526)
- People (2)
- News (424)
- Research (829)
- Events (3)
- Multimedia (32)
- Faculty Publications (461)
Show Results For
- All HBS Web
(1,526)
- People (2)
- News (424)
- Research (829)
- Events (3)
- Multimedia (32)
- Faculty Publications (461)
Clayton S. Rose
Clayton Rose is Baker Foundation Professor of Management Practice and teaches the course Accountability in the Advanced Management Program. His case writing is focused on the how leaders consider the... View Details
Keywords: financial services
- 02 Aug 2011
- First Look
First Look: August 2
cause the accident. It then discusses the response to this spill by BP and the government. This helps provide some context for the decision by the Obama administration to request $20 billion for a fund from... View Details
Keywords: Sean Silverthorne
- Program
Owner/President Management
designed to foster collaborative learning and accelerate personal growth. Review Our Campus Health & Safety Protocols Alumni Status Upon completing the Owner/President Management program, you will become a... View Details
- Program
Leading in the Digital Era
and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling,... View Details
- 2023
- Article
Moral Escalation: Contested Category Emergence and Its Consequences in the Toy Industry
By: Ryann Noe
Preexisting research has outlined the cognitive, competitive, and economic barriers to market category emergence. Yet scholars have paid scant attention to the processes and consequences of moral resistance to nascent categories. Through a longitudinal, qualitative... View Details
Keywords: Moral Sensibility; Market Entry and Exit; Product Positioning; Technology Industry; Consumer Products Industry
Noe, Ryann. "Moral Escalation: Contested Category Emergence and Its Consequences in the Toy Industry." Academy of Management Proceedings (2023).
- Spring 2014
- Article
Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company
By: Andrew Knauer and George Serafeim
Faced with a large percentage of investors that chase short-term returns, companies could benefit by attracting investors with longer-term horizons and incentives that are more consistent with the long-term strategy of the company. The managers of most companies take... View Details
Keywords: Investing; Asset Management; Long-term Investing; Short-termism; Sustainability; Integrated Reporting; Leadership & Corporate Accountability; Pharmaceuticals; Leadership; Integrated Corporate Reporting; Investment; Business and Stakeholder Relations; Corporate Finance; Biotechnology Industry; Pharmaceutical Industry
Knauer, Andrew, and George Serafeim. "Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company." Journal of Applied Corporate Finance 26, no. 2 (Spring 2014): 57–64.
- Web
Frequently Asked Questions
Need Help? Find Answers and Support Here Curious about what to expect when coming to campus? Please visit our health & safety protocols page. For the latest coronavirus... View Details
- 2022
- Working Paper
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives
By: Ariel Dora Stern
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
Keywords: AI and Machine Learning; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Technological Innovation; Medical Devices and Supplies Industry
Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." NBER Working Paper Series, No. 30639, December 2022.
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details
Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Pharmaceutical Industry; Health Industry; United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.
- January 2014
- Case
The Weather Company
New CEO David Kenny transformed The Weather Company in less than two years from a primary identity as a cable television channel to a multi-platform digital company innovating in the uses of weather data. He assesses progress and considers strategic choices and... View Details
Keywords: Innovation; Strategy; Strategic Change; Change Management; Expansion; Weather; Growth and Development Strategy; Innovation and Invention; Technology Industry
Kanter, Rosabeth Moss. "The Weather Company." Harvard Business School Case 314-083, January 2014.
- 05 Jul 2023
- What Do You Think?
How Are Middle Managers Falling Down Most Often on Employee Inclusion?
(DEI)—the holy trinity of organizational development at present. Team members with diverse backgrounds, especially in creative types of work, have been shown to deliver better ideas and bottom-line results than those in less diverse teams... View Details
Keywords: by James Heskett
- November 2006 (Revised February 2007)
- Case
Microsoft Xbox: Changing the Game?
By: Andrei Hagiu
In September 1999, the Microsoft Xbox team was wondering which strategic choices would give it the best chance against the upcoming Sony PlayStation 2. Initially called "Project Midway" within Microsoft, the console project was intended to counter the perceived threat... View Details
Keywords: Customers; Recruitment; Leadership; Management Teams; Multi-Sided Platforms; Two-Sided Platforms; Production; Strategy; Competition; Expansion; Video Game Industry; Texas
Hagiu, Andrei. "Microsoft Xbox: Changing the Game?" Harvard Business School Case 707-501, November 2006. (Revised February 2007.)
- Program
Senior Executive Leadership Program—India
carefully designed to facilitate your growth. Your learning will take place on your own, in your small learning group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & View Details
- Article
Health Equity, Schooling Hesitancy, and the Social Determinants of Learning
By: Meira Levinson, Alan C. Geller, Joseph G. Allen and John D. Macomber
At least 62 million K-12 students in North America—disproportionately low-income children of color— have been physically out of school for over a year due to the COVID-19 pandemic. These children are at risk of significant academic, social, mental, and physical harm... View Details
Keywords: COVID-19; Public Health; Air Quality; Social Determinants Of Health; Schooling Hesitancy; Vaccine Hesitancy; Racial Injustice; Inequity; Inequality; Health Pandemics; Education; Health Care and Treatment; Policy; Race; Equality and Inequality
Levinson, Meira, Alan C. Geller, Joseph G. Allen, and John D. Macomber. "Health Equity, Schooling Hesitancy, and the Social Determinants of Learning." Art. 100032. Lancet Regional Health – Americas 2 (October 2021).
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- 2024
- Chapter
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives
By: Ariel Dora Stern
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." Chap. 4 in The Economics of Artificial Intelligence: Health Care Challenges, edited by Ajay Agrawal, Joshua Gans, Avi Goldfarb, and Catherine E. Tucker, 107–138. Chicago and London: University of Chicago Press, 2024.
- November 2020
- Case
Truebird—An AlleyCorp Venture
By: Shikhar Ghosh and Shweta Bagai
In December 2018, Kevin Ryan and Wendy Tsu faced an important decision – to finalize the CEO candidate for Truebird, an innovative, automated coffee café concept. Like many of AlleyCorp and Ryan’s companies, Truebird started with the observation of an unmet need – an... View Details
Keywords: Startup; Hiring; Staffing; Recruiting; Business Startups; Finance; Leadership; Management Skills; Management Teams; Jobs and Positions; Job Interviews; Human Resources; Recruitment; Selection and Staffing; Technology Industry; Food and Beverage Industry; United States
Ghosh, Shikhar, and Shweta Bagai. "Truebird—An AlleyCorp Venture." Harvard Business School Case 821-030, November 2020.
- Program
Creating Brand Value
facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We... View Details
- November 2017
- Case
The 'Wonder Drug' That Killed Babies
By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Public Administration Industry; United States; United Kingdom; Australia; Germany; Europe
Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.
- 29 Mar 2011
- Working Paper Summaries
Risky Trust: How Multi-entity Teams Develop Trust in a High Risk Endeavor
Keywords: by Faaiza Rashid & Amy C. Edmondson